CN102198224B - Medicinal composition for treating gastrointestinal tract diseases - Google Patents
Medicinal composition for treating gastrointestinal tract diseases Download PDFInfo
- Publication number
- CN102198224B CN102198224B CN2011101378771A CN201110137877A CN102198224B CN 102198224 B CN102198224 B CN 102198224B CN 2011101378771 A CN2011101378771 A CN 2011101378771A CN 201110137877 A CN201110137877 A CN 201110137877A CN 102198224 B CN102198224 B CN 102198224B
- Authority
- CN
- China
- Prior art keywords
- gastrointestinal tract
- rhizoma
- medicinal composition
- pharmaceutical composition
- tract diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a medicinal composition for treating gastrointestinal tract diseases, which is prepared from the following Chinese herbal medicines: bletilla, largehead atractylodes rhizome, alum, yanhusuo, astragalus, bupleurum, bitter orange and liquoric root. Due to the adoption of natural medicines, the medicinal composition for treating the gastrointestinal tract diseases has the advantages of quick response, good curative effect and no toxic or side effect.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of pharmaceutical composition of treating gastroenteropathy.
Background technology
Gastroenteropathy is the common multiple disease of harm health of people; The clinical symptoms of gastropathy is main with pain; Simultaneously also with cold syndrome of the stomach, gastric acid, feel sick, symptoms such as flatulence, vomiting: its pathogeny mainly is because cold-evil visitor in stomach, causes mechanism of qi to be obstructed and pain.And the clinical symptoms of intestinal tract disease is main with diarrhoea mainly; This disease morbidity main cause is due to the diet; Its pathogeny is to experience the heresy of heat-damp in summer cold and heat, impairing the spleen and stomach, and hyperalimentation undermines taste, injures intestinal and arrives.And often morbidity simultaneously of these two kinds of diseases in clinical.
The medicine that is used to treat gastrointestinal disease at present is a lot.As treat gastropathy JIANWEI XIAOSHI PIAN, QIZHIWEITONG CHONGJI, stomach peace etc. are arranged, the treatment intestinal tract disease berberine, WANGSHI BAOCHI WAN etc. are arranged.But the drug effect of these medicines of said medicine is all very single, controls stomach and can not doublely control intestinal, controls intestinal and can not doublely control stomach.Existing medicine also exists drug action slow, and the course of treatment is long, and problem such as actual efficacy is not obvious.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition of treating gastroenteropathy.
In order to realize the object of the invention; The present invention provides a kind of pharmaceutical composition of treating gastroenteropathy, and it is to be processed by weight by following bulk drugs: Pseudobulbus Bletillae (Rhizoma Bletillae) 20-35, Rhizoma Atractylodis Macrocephalae 15-20, Alumen 15-20, Rhizoma Corydalis 10-15, Radix Astragali 15-25, Radix Bupleuri 15-25, Fructus Aurantii 20-30 and Radix Glycyrrhizae 10-15.
Preferably, it is to be processed by weight by following bulk drugs: the Pseudobulbus Bletillae (Rhizoma Bletillae) 30, the Rhizoma Atractylodis Macrocephalae 18, Alumen 18, Rhizoma Corydalis 13, the Radix Astragali 20, Radix Bupleuri 20, Fructus Aurantii 25 and Radix Glycyrrhizae 13.
Preferably, said pharmaceutical composition is processed tablet, dispersible tablet, buccal tablet, powder or pill.
Use natural drug in the medicine of treatment gastroenteropathy of the present invention, so its advantage that has instant effect, good effect, has no side effect.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 pill of the present invention
Get the Pseudobulbus Bletillae (Rhizoma Bletillae) 300 grams, the Rhizoma Atractylodis Macrocephalae 180 grams, Alumen 180 grams, Rhizoma Corydalis 130 grams, the Radix Astragali 200 grams, Radix Bupleuri 200 grams, Fructus Aurantii 250 grams and Radix Glycyrrhizae 130 grams, pulverize, cross 80 mesh sieves, add Mel 30 grams and mix round as a ball one-tenth 100 balls.
The clinical observation of experimental example Drug therapy gastroenteropathy of the present invention
(1) test case standard
Tcm diagnosis standard: have following clinical manifestation: gastral cavilty distending pain, anorexia, abdominal distention after meal, big loose stool are thin, limbs asthenia, hematemesis, black stool, lusterless complexion, acid regurgitation, red tongue, yellow fur, floating and thready pulse.
Western medicine diagnose standard: relate to diseases such as doctor trained in Western medicine stomach, duodenal ulcer, acute or chronic gastritis (shallow table property, erosive, contracting property of Rhizoma Zingiberis Recens), acute chronic enteritis, gastrointestinal dysfunction and all carry out by the up-to-date diagnostic criteria of this disease.
Exclusion standard: merge liver, kidney, the heart, disease of hematopoietic system, the psychotic with do not meet the standard of including in, do not take medicine to affect the treatment and observe etc. by regulation.
(2) pill of preparation among test medication: the embodiment 1
Usage: every day twice, each two balls, one month is a course of treatment.
(3) health giving quality observation
Cardinal symptom: upper abdominal pain number of times, degree; Stool have or not black stool, shapeless, have loose bowels; Abdominal distention; Acid regurgitation.
Minor symptom: belch, feel sick, loss of appetite, body be tired.
Safety observation: carry out blood, urine, just routine test regulating liver-QI kidney function test.
(4) clinical efficacy criterion
Clinical recovery: cardinal symptom and minor symptom are all eliminated, ulcer focus or gastritis foci disappearance.
Produce effects: cardinal symptom, minor symptom are obviously improved, and ulcer focus or gastritis focus disappear basically.
Effectively: cardinal symptom and minor symptom all have improvement, and focus dwindles 40%.
Invalid: cardinal symptom, minor symptom do not have improvement, and focus is less than 30%.
(5) result and analysis
Choose patient's 50 examples that meet above-mentioned diagnostic criteria, wherein minimal ages is 8 years old, maximum age 70 years old, 38.4 years old mean age, the shortest course of disease 3 days, the longest January.Use the pill among the embodiment 1.After a course of treatment, all patients' cardinal symptom and minor symptom are all eliminated, and ulcer focus or gastritis foci disappearance all meet the criterion of clinical recovery.And during whole treatment, do not observe tangible untoward reaction.
After treating a course of treatment, all the patient is followed up a case by regular visits to weekly, continue half a year, find the sign of recurrence.
Claims (3)
1. pharmaceutical composition of treating stomach, intestinal ulcer, gastritis or gastrointestinal dysfunction; It is characterized in that it is to be processed by weight by following bulk drugs: Pseudobulbus Bletillae (Rhizoma Bletillae) 20-35, Rhizoma Atractylodis Macrocephalae 15-20, Alumen 15-20, Rhizoma Corydalis 10-15, Radix Astragali 15-25, Radix Bupleuri 15-25, Fructus Aurantii 20-30 and Radix Glycyrrhizae 10-15.
2. the pharmaceutical composition of treatment stomach according to claim 1, intestinal ulcer, gastritis or gastrointestinal dysfunction; It is characterized in that it is to be processed by weight by following bulk drugs: the Pseudobulbus Bletillae (Rhizoma Bletillae) 30, the Rhizoma Atractylodis Macrocephalae 18, Alumen 18, Rhizoma Corydalis 13, the Radix Astragali 20, Radix Bupleuri 20, Fructus Aurantii 25 and Radix Glycyrrhizae 13.
3. the pharmaceutical composition of treatment stomach according to claim 1 and 2, intestinal ulcer, gastritis or gastrointestinal dysfunction is characterized in that said pharmaceutical composition is processed tablet, powder or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101378771A CN102198224B (en) | 2011-05-26 | 2011-05-26 | Medicinal composition for treating gastrointestinal tract diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101378771A CN102198224B (en) | 2011-05-26 | 2011-05-26 | Medicinal composition for treating gastrointestinal tract diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102198224A CN102198224A (en) | 2011-09-28 |
| CN102198224B true CN102198224B (en) | 2012-07-25 |
Family
ID=44659379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101378771A Expired - Fee Related CN102198224B (en) | 2011-05-26 | 2011-05-26 | Medicinal composition for treating gastrointestinal tract diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102198224B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102648962A (en) * | 2012-04-20 | 2012-08-29 | 苏州爱斯欧蒂生物科技有限公司 | Medicine for treating gastrointestinal diseases |
| CN106075266A (en) * | 2016-07-22 | 2016-11-09 | 铜陵宏正网络科技有限公司 | A kind of Chinese medicine treating chronic erosive gastritis |
| CN111759980A (en) * | 2020-08-06 | 2020-10-13 | 杨波 | Traditional Chinese medicine formula for treating peptic ulcer and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895291A (en) * | 2006-06-09 | 2007-01-17 | 陈永丽 | Nano-Chinese medicinal biological product and its preparation |
-
2011
- 2011-05-26 CN CN2011101378771A patent/CN102198224B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102198224A (en) | 2011-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101249235B (en) | Chinese medicine for curing esophagus cancer and method of preparing the same | |
| CN103405701B (en) | A kind of medicine treating gastroenteropathy and preparation method thereof | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN101607074A (en) | A kind of drug regimen for the treatment of chronic gastritis and preparation method thereof | |
| CN102198224B (en) | Medicinal composition for treating gastrointestinal tract diseases | |
| CN104013756A (en) | Traditional Chinese medicine composition for preventing and treating diarrhea and application of traditional Chinese medicine composition | |
| CN103800748A (en) | Traditional Chinese medicinal composition for treating dyspepsia | |
| CN100453103C (en) | Medicine for treating children's stomachache and its prepn | |
| CN104474204A (en) | Pharmaceutical composition for treating infantile diarrhea | |
| CN103721219B (en) | A kind of Chinese medicine composition treating chronic gastropathy | |
| CN103479947B (en) | The preparation method of control constipation medicine | |
| CN105832991A (en) | Traditional Chinese medicine composition for treating gastritis | |
| CN104721256A (en) | Anwei Yang extract as well as preparation method and medical application thereof | |
| CN103251918A (en) | Medicine for treating gastrointestinal tract diseases | |
| CN104225016B (en) | A kind of pharmaceutical composition treating due to weakness of spleen and stomach chronic atrophic gastritis | |
| CN100438895C (en) | Medicine for treating stomachache and method for preparing same | |
| CN103463452B (en) | A kind of medicine for the treatment of chronic atrophic gastritis | |
| CN105055812A (en) | Traditional Chinese medicine for treating gastroesophageal reflux disease with syndrome of heat stagnation in liver and stomach | |
| CN104784650A (en) | Pharmaceutical preparation for clinical nursing of gastric ulcer | |
| CN100450523C (en) | Chinese materia medica preparation for treating gastric disease | |
| CN103479948B (en) | The anti-medicine treated constipation | |
| CN103341126A (en) | Chinese medicine composite for treating chronic gastritis and preparation method thereof | |
| CN105213780A (en) | A kind of Chinese medicine composition and application thereof for the treatment of chronic gastritis | |
| CN104784651A (en) | Method for preparing pharmaceutical preparation for treating gastric ulcer | |
| CN105106879A (en) | Traditional Chinese medicine preparation for treating gastric ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20140526 |